What is ZeOmega?
Founded in 2001 and headquartered in Plano, Texas, ZeOmega offers comprehensive population health management solutions tailored for a diverse clientele. Its platform serves commercial health plans, Medicaid managed care plans, Medicare Advantage plans, health systems, and Accountable Care Organizations (ACOs). The company's focus on optimizing health outcomes and managing costs positions it as a key player in the evolving healthcare landscape, leveraging technology to address complex challenges within the managed care and provider sectors.
How much funding has ZeOmega raised?
ZeOmega has raised a total of $23.5M across 2 funding rounds:
Private Equity
$21.5M
Debt
$2M
Private Equity (2013): $21.5M with participation from Bregal Sagemount, BlueCross BlueShield Venture Partners, and Sandbox Industries
Debt (2020): $2M led by PPP
Key Investors in ZeOmega
Bregal Sagemount
Bregal Sagemount is a private equity firm specializing in growth capital and emerging growth investments, focusing on middle market, later stage, and mature companies.
BlueCross BlueShield Venture Partners
BlueCross BlueShield Venture Partners invests in emerging companies of strategic relevance to Blue Cross and Blue Shield Plans, managing over $500 million in capital across three funds.
Sandbox Industries
Sandbox Industries is a venture capital firm that invests in startups at the intersection of entrepreneurial thinking and large corporate enterprises, with a focus on consumer technology, food, agriculture, and healthcare.
What's next for ZeOmega?
The recent major strategic investment signifies a pivotal moment for ZeOmega, likely enabling accelerated growth and further development of its population health management technologies. This capital infusion is expected to bolster its market penetration and enhance its service offerings to a broader range of healthcare entities. The company's trajectory suggests a continued focus on innovation and strategic partnerships to navigate the complexities of value-based care and improve patient outcomes across various healthcare delivery models.
See full ZeOmega company page
